Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene. (Q46137549)
Jump to navigation
Jump to search
scientific article published on 29 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene. |
scientific article published on 29 January 2009 |
Statements
Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene (English)
Iain D O'Neill
1 reference
29 January 2009